Sponsor:
Sutter Health
Code:
NCT04092647
Conditions
Chemo Fog
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ashwagandha
Placebo
Brief summary:
Conditions
Chemo Fog
Study ID
NCT04092647
Start date
Jan 1, 2023
Status verified date
Jun, 2023
Completion date
Jul 1, 2025
Anticipated
Primary completion date
Dec 31, 2024
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
80 participants
Anticipated
Allocation
Randomized
Intervention Model
Crossover
Primary purpose
Treatment
Arms
experimental: ashwagandha
placebo comparator: placebo
Interventions
Ashwagandha
Placebo
Primary outcome measure
Central contacts
Locations
Sutter Cancer Center
Recruiting
Sacramento, California, United States, 95816
Contacts
Principal Investigator:
Deepti Behl, MD
Sponsor
Sutter Health
Last update posted
Jun 15, 2023
Last verified
Jun, 2023
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Sutter Health on 2023-06-15.